Patent · US Active

Influenza virus mutants and uses therefor

US9919042B2 · kind B2 · utility

2Cited by

4References

20Claims

0Family size

Assignee

FluGen, Inc. · US

Inventors

Pamuk Bilsel · San Diego, US
Yasuko Hatta · Madison, US

Key dates

Filing date	Feb 10, 2016
Grant date	Mar 20, 2018
Priority date	—
Expiry date	Mar 6, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16262
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.